UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: November 21, 2017
Accession Number: 0001654954-17-010672
Submission Type: POS AM
CIK: 0001069308
Company Name: Acer Therapeutics Inc.
File Number: 333-208314